Imidazoles
Imidazoles are five-membered ring heterocycles containing two nitrogen atoms. These compounds play a crucial role in organic synthesis and medicinal chemistry, especially for their antifungal and antimicrobial properties. At CymitQuimica, we offer a diverse selection of high-quality imidazoles to support your research and industrial needs.
Subcategories of "Imidazoles"
Products of "Imidazoles"
2-Ethyl-4-methyl-1H-imidazole-5-carboxylic acid
Ref: 10-F776265
1g | Discontinued | Request information |
(4-methyl-1H-imidazol-2-yl)methanol hydrochloride
Ref: 10-F392036
1g | Discontinued | Request information | |
5g | Discontinued | Request information | |
100mg | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |
1-(5-(3-Ethyl-1,2,4-oxadiazol-5-yl)pyridin-2-yl)-1H-imidazole-4-carboxylic acid
Ref: 10-F727946
1g | Discontinued | Request information |
2,2-diethoxy-1-(1-methyl-1H-imidazol-2-yl)ethen-1-ol
Ref: 10-F653435
1g | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |
Ref: 10-F724358
1g | Discontinued | Request information | |
2g | Discontinued | Request information | |
5g | Discontinued | Request information | |
500mg | Discontinued | Request information |
Ref: 10-F667619
1g | Discontinued | Request information |
3-(5-Bromo-2-methyl-4-nitro-1H-imidazol-1-yl)propanenitrile
Ref: 10-F436192
1g | Discontinued | Request information | |
5g | Discontinued | Request information | |
10g | Discontinued | Request information |
4-(4,5-Dimethyl-1h-imidazol-1-yl)aniline
Ref: 10-F656750
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |
n-(3-(1h-Imidazol-1-yl)propyl)pentan-3-amine
Ref: 10-F709433
1g | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |
Ref: 10-F669524
1g | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |
Ref: 10-F660611
1g | Discontinued | Request information | |
2.5g | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |
Ref: 10-F370437
1g | Discontinued | Request information | |
250mg | Discontinued | Request information |
2-(1-Ethyl-1h-imidazol-2-yl)acetic acid
Ref: 10-F740073
1g | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |
Ref: 10-F366406
1g | Discontinued | Request information | |
5g | Discontinued | Request information | |
25g | Discontinued | Request information |
(S)-1-(1,3-Dicarboxypropyl)-4,5-dimethyl-1h-imidazole 3-oxide
Ref: 10-F687036
250mg | Discontinued | Request information |
2-Methyl-5-((2-methyl-1h-imidazol-1-yl)methyl)-1,3,4-oxadiazole
Ref: 10-F689038
1g | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |
5-(4-bromophenyl)-1-[4-(difluoromethoxy)phenyl]-2,3-dihydro-1H-imidazole-2-thione
Ref: 10-F678289
1g | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |
5-((4,5-Dichloro-1H-imidazol-1-yl)methyl)-3-(furan-2-yl)-1,2,4-oxadiazole
Ref: 10-F752196
500mg | Discontinued | Request information |
1-(Thiophen-2-ylmethyl)-1h-imidazol-2-amine
Ref: 10-F698544
1g | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |
5-(1h-Imidazol-2-yl)-4-phenyl-1,3-thiazol-2-amine
Ref: 10-F659288
1g | Discontinued | Request information | |
5g | Discontinued | Request information | |
2.5g | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |